GL1X · GenesisL1 explorer

Research workbench

Crystal structure of M. tuberculosis InhA in complex with NAD+ and 3-[3-(trifluoromethyl)phenyl]prop-2-enoic acid

Analyse Crystal structure of M. tuberculosis InhA in complex with NAD+ and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SQ5
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.84
Source
Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P9WGR1
Ligands
NAD, LRW
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · resolution 1.84 · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26746% helix, 16% strandP9WGR1

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • LRW · (~{E})-3-[3-(trifluoromethyl)phenyl]prop-2-enoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16510.790.8353NAD, LRW
2540.390.8112empty

Compared structures

  • 6SQ5 · Crystal structure of M. tuberculosis inha in complex with NAD+ and 3… · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WGR1 · AlphaFold monomer V2.0 prediction for enoyl-[acyl-carrier-protein] reductase [NADH]… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.